Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · C41E25803111159706
Oméga 3 2000 mg EPA : 660mg / DHA : 440mg - 200 gélules Huile de piosson origine France
longtail
3P
MEDICAMENTS
Last 4 weeks demand
1
new activity (no prior baseline)
Offer Stock
1
Σ Stock across 1 live offer (1P + 3P) · 2026-10-14
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-14 snapshot
Unit price
MAD 382
avg of last 16 sells · latest 2026-10-01
C41E25803111159706
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-10-05 · Total forecast: 32 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Oméga 3 2000 mg EPA : 660mg / DHA : 440mg - 200 gélules Huile de piosson origine France · in the longtail cohort · last 4 weeks 1 units, new activity (no prior baseline) · on-hand 2 units
Signals the model saw
- Cohort: longtail (182 days of history, — units sold over 52 weeks)
- Volatility (CV): 0.50 — moderate
- Recent trend: last 4w = 1 units · prev 4w = 0 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 0.0 units |
| Realistic forecast — next 4 weeks | 0.0 units |
| Realistic forecast — next 3 months | 0.0 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 0.4 units |
| Optimistic — next week | 2.8 units |
| Optimistic — next 4 weeks (reorder target) | 10.2 units |
| Optimistic — next 3 months (quarterly PO target) | 32.3 units |
| Legacy μ/wk (reorder pipeline) | — |
| Revenue exposure — optimistic, 3 months | MAD 12.3K |